Established in 1996, QIMA Life Sciences is a Contract Research Organization that specializes in cellular and molecular pharmacology. As the life science division of the QIMA group, we bring together QIMA Bioalternatives, QIMA Synelvia, Newtone Technologies, and Monasterium Laboratory to offer a comprehensive range of solutions.
QIMA Life Sciences offers a range of assays, including in silico screening, clinical imaging, in vitro and ex vivo assays, and non-invasive clinical sample bioanalysis. The "Blood assay solutions" for fresh whole blood testing are exclusively available at QIMA Life Sciences.
QIMA Life Sciences is dedicated to developing in vitro methods as an alternative to animal experimentation, providing solutions for preclinical research, drug candidate development, and cosmetic active ingredients and formulations.
In addition to product evaluation and development, QIMA Life Sciences offers customized competitive services based on collaborative innovation, assisting the health industry with its strategic choices.
Assays are conducted at three French sites and one German site, with 100 experts and four laboratories of over 2000 square meters. QIMA Life Sciences helps big international cosmetics and pharmaceutical groups innovate in project conceptualization, substantiate and support product claims, and drive marketing and R&D.